National Cancer Hospital

Chuo Ku, Tokyo 104 0045

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma — Stopped early